The Imaging Genetic Study of Schizophrenia and Family

NCT ID: NCT01259232

Last Updated: 2019-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the brain abnormalities and the association with gene in schizophrenia patients and their relatives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

schizophrenia patients,untreated

No interventions assigned to this group

schizophrenia relatives

No interventions assigned to this group

controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of schizophrenia(DSM-IV)
* total score of PANSS\>64

Exclusion Criteria

* other psychiatric disease,
* organic disease
* neurological disease
* unstable physiological status
* age\>65
* pregnant
Minimum Eligible Age

15 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese Academy of Sciences

OTHER_GOV

Sponsor Role collaborator

Kunming Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yuqi Cheng

Kunming Medical University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiufeng Xu

Role: STUDY_DIRECTOR

Psychiatry Department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Psychiatry department, The 1st Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuqi Cheng

Role: CONTACT

8613888122013

Xiufeng Xu

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiufeng Xu

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KMC2010L4

Identifier Type: -

Identifier Source: secondary_id

SCH001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychiatric Genotype/Phenotype Project Repository
NCT00762866 ENROLLING_BY_INVITATION